Premium
F2‐01‐02: Pathway Discovery, Validation and Compound Identification for Alzheimer's Disease
Author(s) -
Jager Philip,
Mostafavi Sara,
Gaiteri Chris,
Sullivan Sarah,
White Charles,
Pearse Tracy,
Bennett David A.
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.381
Subject(s) - neuroscience , computational biology , biology , endophenotype , dorsolateral prefrontal cortex , epigenomics , alzheimer's disease , bioinformatics , gene , cognition , disease , prefrontal cortex , genetics , medicine , gene expression , dna methylation
COMPOUND IDENTIFICATION FOR ALZHEIMER’S DISEASE Philip de Jager, Sara Mostafavi, Chris Gaiteri, Sarah Sullivan, Charles White, Tracy Pearse, David A. Bennett, Harvard Medical School, Boston, MA, USA; University of British Columbia, Vancouver, BC, Canada; 3 RUSH University, Chicago, IL, USA; 4 BWH, Boston, MA, USA; Rush University Medical Center, Chicago, IL, USA. Contact e-mail: pdejager@rics.bwh.harvard.edu
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom